449 related articles for article (PubMed ID: 32328845)
21. Oral Therapy for the Treatment of Transthyretin-Related Amyloid Cardiomyopathy.
Nuvolone M; Girelli M; Merlini G
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555787
[TBL] [Abstract][Full Text] [Related]
22. Updates in Cardiac Amyloidosis Diagnosis and Treatment.
Stern LK; Kittleson MM
Curr Oncol Rep; 2021 Mar; 23(4):47. PubMed ID: 33725199
[TBL] [Abstract][Full Text] [Related]
23. Advances in pharmacotherapy for cardiac amyloidosis.
Spoladore R; Falasconi G; Marcatti M; Di Maio S; Fiore G; Slavich M; Margonato A; Turco A; Fragasso G
Expert Opin Pharmacother; 2021 Mar; 22(4):469-481. PubMed ID: 33043721
[TBL] [Abstract][Full Text] [Related]
24. Diagnosis and treatment of transthyretin amyloidosis cardiomyopathy: A position statement of the Polish Cardiac Society.
Grzybowski J; Podolec P; Holcman K; Gawor-Prokopczyk M; Jankowska E; Kostkiewicz M; Dąbrowska-Kugacka A; Lipowska M; Mazurkiewicz Ł; Rajtar-Salwa R; Rubiś P; Straburzyńska-Migaj E; Szczygieł J; Mitkowski P
Kardiol Pol; 2023; 81(11):1167-1185. PubMed ID: 37768101
[TBL] [Abstract][Full Text] [Related]
25. Cardiac amyloidosis: An underdiagnosed/underappreciated disease.
Manolis AS; Manolis AA; Manolis TA; Melita H
Eur J Intern Med; 2019 Sep; 67():1-13. PubMed ID: 31375251
[TBL] [Abstract][Full Text] [Related]
26. Amyloid cardiomyopathy.
Kristen AV
Herz; 2020 May; 45(3):267-271. PubMed ID: 32107564
[TBL] [Abstract][Full Text] [Related]
27. Treating amyloid transthyretin cardiomyopathy: lessons learned from clinical trials.
Tomasoni D; Bonfioli GB; Aimo A; Adamo M; Canepa M; Inciardi RM; Lombardi CM; Nardi M; Pagnesi M; Riccardi M; Vergaro G; Vizzardi E; Emdin M; Metra M
Front Cardiovasc Med; 2023; 10():1154594. PubMed ID: 37288260
[TBL] [Abstract][Full Text] [Related]
28. Transthyretin Cardiac Amyloidosis: An Evolution in Diagnosis and Management of an "Old" Disease.
Smiley DA; Rodriguez CM; Maurer MS
Cardiol Clin; 2022 Nov; 40(4):541-558. PubMed ID: 36210137
[TBL] [Abstract][Full Text] [Related]
29. RNA-targeting and gene editing therapies for transthyretin amyloidosis.
Aimo A; Castiglione V; Rapezzi C; Franzini M; Panichella G; Vergaro G; Gillmore J; Fontana M; Passino C; Emdin M
Nat Rev Cardiol; 2022 Oct; 19(10):655-667. PubMed ID: 35322226
[TBL] [Abstract][Full Text] [Related]
30. Cardiac amyloidosis: a review of the literature.
de Marneffe N; Dulgheru R; Ancion A; Moonen M; Lancellotti P
Acta Cardiol; 2022 Oct; 77(8):683-692. PubMed ID: 35852493
[TBL] [Abstract][Full Text] [Related]
31. Multidisciplinary Approaches for Transthyretin Amyloidosis.
Koike H; Okumura T; Murohara T; Katsuno M
Cardiol Ther; 2021 Dec; 10(2):289-311. PubMed ID: 34089151
[TBL] [Abstract][Full Text] [Related]
32. [Neurological manifestations of ATTR amyloidosis].
Pernice HF; Hahn K
Inn Med (Heidelb); 2023 Sep; 64(9):848-854. PubMed ID: 37555967
[TBL] [Abstract][Full Text] [Related]
33. Recent advances in the diagnosis and management of cardiac amyloidosis.
Sher T; Gertz MA
Future Cardiol; 2014 Jan; 10(1):131-46. PubMed ID: 24344669
[TBL] [Abstract][Full Text] [Related]
34. Advances in Diagnosis and Treatment of Cardiac and Renal Amyloidosis.
Law S; Fontana M; Gillmore JD
Cardiol Clin; 2021 Aug; 39(3):389-402. PubMed ID: 34247752
[TBL] [Abstract][Full Text] [Related]
35. Cardiac amyloidosis: where are we today?
Patel KS; Hawkins PN
J Intern Med; 2015 Aug; 278(2):126-44. PubMed ID: 26077367
[TBL] [Abstract][Full Text] [Related]
36. Diagnosis and treatment of transthyretin-related amyloidosis cardiomyopathy.
Teng C; Li P; Bae JY; Pan S; Dixon RAF; Liu Q
Clin Cardiol; 2020 Nov; 43(11):1223-1231. PubMed ID: 32725834
[TBL] [Abstract][Full Text] [Related]
37. Standardising Care and Treatment of Transthyretin Amyloid Cardiomyopathy.
Fontana M; Porcari A; Hawkins PN
Glob Heart; 2023; 18(1):63. PubMed ID: 38028963
[TBL] [Abstract][Full Text] [Related]
38. Cardiac Amyloidosis: Overlooked, Underappreciated, and Treatable.
Rubin J; Maurer MS
Annu Rev Med; 2020 Jan; 71():203-219. PubMed ID: 31986086
[TBL] [Abstract][Full Text] [Related]
39. Insights Regarding the Article "Exploring Transthyretin Amyloid Cardiomyopathy: A Comprehensive Review of the Disease and Upcoming Treatments".
Sandeep B; Ma C; Chen J; Xiao Z
Curr Probl Cardiol; 2024 Jan; 49(1 Pt B):102100. PubMed ID: 37734690
[TBL] [Abstract][Full Text] [Related]
40. Cardiac amyloidosis in African Americans: comparison of clinical and laboratory features of transthyretin V122I amyloidosis and immunoglobulin light chain amyloidosis.
Connors LH; Prokaeva T; Lim A; Théberge R; Falk RH; Doros G; Berg A; Costello CE; O'Hara C; Seldin DC; Skinner M
Am Heart J; 2009 Oct; 158(4):607-14. PubMed ID: 19781421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]